Healthtech & Diagnostics · Lab
AMILI
What AMILI says about itself
AMILI is Southeast Asia's leading precision gut microbiome company, founded in Singapore in 2019, and runs the region's only microbiome transplant bank. It offers clinical gut health testing, microbiome restoration therapy, AI-powered analytics for healthcare partners, and physician-guided probiotic programs, and holds the world's largest multi-ethnic Asian gut microbiome database. Backed by Vulcan Capital and East Ventures, it collaborates with NUS, NUH, and Monash University.
Source: amili.asia, the organization's own site.
What the Atlas verified
AMILI is one of 491 organizations recorded in the Atlas of the Healthspan Economy, one of 28 in Singapore and one of 129 in Asia.
Relationships
Key people
- Jeremy Lim (Co-Founder and CEO)
Is this your organization? Confirm or correct this record.